tiprankstipranks
Bioventix CFO Increases Stake Through Share Purchase
Company Announcements

Bioventix CFO Increases Stake Through Share Purchase

Story Highlights

Don't Miss Our Christmas Offers:

Bioventix ( (GB:BVXP) ) has provided an announcement.

Bioventix plc announced that its Chief Financial Officer, Bruce Hiscock, has purchased 61 ordinary shares of the company under a dividend reinvestment plan. The purchase slightly increased Hiscock’s stake in the company to approximately 0.02 percent of the issued share capital, demonstrating a continued commitment to the company’s growth and market position.

More about Bioventix

Bioventix plc is a UK-based company that specializes in the development and commercial supply of high-affinity monoclonal antibodies, primarily for applications in clinical diagnostics.

YTD Price Performance: -22.66%

Average Trading Volume: 8,136

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £167M

For an in-depth examination of BVXP stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskBioventix Triumphs at AGM; Strengthens Market Position
TipRanks UK Auto-Generated NewsdeskBioventix Gains Increased Investment from Gresham House
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App